The Food and Drug Administration declared an end to the scarcity of Eli Lilly’s highly in-demand weight-loss and diabetes drugs on Thursday.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
In the obesity drug industry, two players have really been throwing their weight around. There isn’t a third in sight.
WW announced on Thursday that it will be laying off employees and cutting costs to the tune of $100 million per year.
Its recent patent adds to several for cryogenic storage that works in tandem with server farms.
Using fake data is “not a panacea” to the security woes these models face.
Despite the buzz, the promises of this tech may be “underhyped,” one expert said.